Skip to main content
. Author manuscript; available in PMC: 2015 Oct 16.
Published in final edited form as: Mol Cell. 2014 Sep 11;56(1):90–103. doi: 10.1016/j.molcel.2014.08.011

Figure 3. nSR100 binds directly upstream of suboptimal 3′ splice sites to promote neural exon inclusion.

Figure 3

(A) nSR100 RNA binding map showing the mean, normalized density of crosslinked sites in 400 nucleotide windows encompassing nSR100-regulated exons (blue) and control non-regulated exons (gray) in 293T cells; ss, splice site.

(B) Top panel, genome browser view of the raw density of nSR100 293T PAR-iCLIP tags surrounding the UGC motif (orange box) upstream of the REST neural exon. Bottom panel, RT-PCR assay monitoring inclusion levels of the REST neural exon upon transfection of wild-type (W) or mutant (M) minigene reporters into 293T cells with and without dox-induced nSR100 expression.

(C) Box plots comparing the 3′ and 5′ splice site strengths of conserved nSR100 target exons (blue) and control, non-regulated exons (white). Asterisks represent significant differences; p values, Wilcoxon rank sum test.

(D) Plots comparing polypyrimidine tract lengths and distances between 3′ splice sites and inferred branch points of nSR100 regulated exons (red), and of PSI-matched control exons (gray) in human; p values, Kolmogorov-Smirnov test.

(E) RT-PCR assays monitoring the effects of mutating UGC motif(s) on inclusion levels of the DAAM1 and MEF2D neural exons. Dox-inducible nSR100-expressing 293T cells were transfected with wild-type (W) minigene reporters (lanes 1-2). 293T cells (not dox-inducible) were transfected with wild-type or mutant (M, M1, M2) reporters, and control (lanes 3, 5, 7) or PTBP1 and PTBP2 siRNAs (lanes 4, 6, 8). PPT, polypyrimidine tract. Asterisk represents a product from usage of an alternative splice site. See also Figure S3.